3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
32
Breast Neoplasms
25
Fallopian Tube Neoplasms
21
Multiple Myeloma
18
Carcinoma, Ovarian Epithelial
14
Lymphoma
8
Triple Negative Breast Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hodgkin Disease
3
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Patient Participation
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Interventions
pembrolizumab
120
Cisplatin
26
Carboplatin
24
Paclitaxel
21
Docetaxel
17
lenvatinib
15
Pemetrexed
12
Fluorouracil
12
Saline Solution
11
Capecitabine
10
epacadostat
8
Oxaliplatin
7
Gemcitabine
7
Leucovorin
5
Cetuximab
5
130-nm albumin-bound paclitaxel
5
olaparib
4
enzalutamide
4
Irinotecan
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
trifluridine tipiracil drug combination
3
regorafenib
3
Prednisone
3
Dexamethasone
3
Radiotherapy
2
Ipilimumab
2
Glucose
2
Etoposide
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
liposomal doxorubicin
×
Clear all
No trials found.